Agents screened for lipid droplet fusion activity.

Primary targets highlighted in bold. PKA, cAMP-dependent protein kinase; S6K1, p70 ribosomal protein S6 kinase 1; ROCK-II, Rho-dependent protein kinase II; MSK-1, mitogen- and stress-activated protein kinase 1; PKBα, protein kinase B α; AMPK, AMP-activated protein kinase; PKG, cGMP -dependent protein kinase; CaCMK-II, calcium/calmodulin-dependent protein kinase II; MLCK, myosin light chain kinase; ERK1/2, extracellular-signal-related kinase 1/2; PRK2, protein kinase C-related protein kinase 2; RSK1/2, p90 ribosomal protein S6 kinase; PKD1, serine-threonine protein kinase D1; MEK, MAPK kinase (also called MKK); PRAK, p38-regulated/activated kinase; SAPK2a, stress-activated protein kinase 2a (also called p38); SAPK2b, stress activated protein kinase 2b (also called p38β2); PDK-1, 3-phosphoinositide-dependent protein kinase 1; PKC, protein kinase C; BIM-I, bisindolylmaleimide I.